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Abstract
Background Sliding hip screws (SHSs) and intramedul-
lary (IM) nails are well-documented implants for simple
two-part intertrochanteric fractures; however, there is no
consensus regarding which type of implant is better.
Questions/purposes We asked whether patients with
simple two-part intertrochanteric fractures treated with IM
nailing had (1) a lower reoperation rate and (2) less pain
and better quality of life than patients treated with SHSs.
Methods We used data from the Norwegian Hip Fracture
Register on 7643 operations for simple two-part intertro-
chanteric fractures (AO/OTA Type A1) treated with an
SHS (n = 6355) or an IM nail (n = 1288) between 2005 and
2010. Kaplan-Meier analysis was used to assess reopera-
tion percentages and a Cox regression model was used to
assess the risk of reoperation. Questionnaires regarding
pain and quality of life were answered by the patients at 4,
12, and 36 months postoperatively.
Results We found an increased risk of reoperation after
IM nailing within 1 postoperative year: 2.4% and 4.2% for
SHS and IM nails, respectively. The difference persisted
with time: 4.5% and 7.1% at 3 years. We also found minor
differences for pain and quality of life which we judged
clinically unimportant.
Conclusions Based on our ﬁndings and a critical review
of the literature, we suggest an SHS is likely the preferred
implant for simple two-part intertrochanteric fractures.
Level of Evidence Level III, therapeutic study. See the
Instructions for Authors for a complete description of
levels of evidence.
Introduction
Implant selection for intertrochanteric fractures remains
controversial, and whether intertrochanteric fractures are
best treated with a sliding hip screw (SHS) or an intra-
medullary (IM) nail has not been conclusively answered in
the literature [17, 24]. Most randomized clinical trials
(RCTs) [5, 23, 27, 29–31] found no major difference in
long-term functional outcome between the two groups of
implants. However, a meta-analysis [16] concluded higher
fracture ﬁxation failure and reoperation rates occurred after
The institution of one or more of the authors (KM, LIH, JEG, BE,
JMF) has received, during the study period, funding from The
Regional Health Board of Western Norway (Stavanger, Norway).
All ICMJE Conﬂict of Interest Forms for authors and Clinical
Orthopaedics and Related Research editors and board members are
on ﬁle with the publication and can be viewed on request.
Clinical Orthopaedics and Related Research neither advocates nor
endorses the use of any treatment, drug, or device. Readers are
encouraged to always seek additional information, including FDA
approval status, of any drug or device before clinical use.
Each author certiﬁes that his or her institution approved the human
protocol for this investigation, that all investigations were conducted
in conformity with ethical principles of research, and that informed
consent for participation in the study was obtained.
This work was performed at the Haukeland University Hospital
(Bergen, Norway) and University of Bergen (Bergen, Norway).
K. Matre (&), L. I. Havelin, J.-E. Gjertsen,
B. Espehaug, J. M. Fevang
Department of Orthopaedic Surgery, Haukeland University
Hospital, Jonas Lies Vei 65, 5021 Bergen, Norway
e-mail: kjell.matre@helse-bergen.no
L. I. Havelin
Department of Surgical Sciences, University
of Bergen, Bergen, Norway
B. Espehaug
Department of Health and Social Sciences, Bergen
University College, Bergen, Norway
123
Clin Orthop Relat Res (2013) 471:1379–1386
DOI 10.1007/s11999-012-2728-2
Clinical Orthopaedics
and Related Research®
A Publication of  The Association of Bone and Joint Surgeons®
IM nailing. Jones et al. [16] concluded an IM nail should
not be recommended for stable intertrochanteric fractures.
Even for unstable fractures, they found no advantage in
using an IM nail. Their ﬁndings, however, might have been
skewed by the inclusion of studies on the earliest com-
mercially available trochanteric nails and a learning curve
among surgeons beginning to use trochanteric nailing.
Some of the earlier nails were associated with higher
failure rates, postoperative femoral fractures in particular,
and are no longer in use [4, 8, 10, 25]. Bhandari et al.
assessed the effects of time and different generations of
implants (GammaTM nails, Stryker, Kalamazoo, MI, USA)
on femoral shaft fractures after nailing [6]. They found the
differences in femoral fracture risk between the SHS and
the GammaTM nail lessened and eventually disappeared
and therefore recommended the ﬁndings from earlier RCTs
and meta-analyses should be interpreted with caution.
Thus, despite numerous publications on this topic, ﬁrm
conclusions regarding the best implant for intertrochanteric
fractures cannot be drawn and recommendations have
diverged. In addition, a consistent fracture classiﬁcation
has not always been used, making the interpretation of data
more difﬁcult. Nevertheless, there has been a trend toward
more IM nailing in intertrochanteric fractures, even though
evidence supporting its increased use is missing [2, 26].
We have seen a similar but less pronounced trend in our
country, but we still treat nearly 80% of all intertrochan-
teric fractures with an SHS [21].
To clarify the distinctions between these two implants,
we studied a large group of patients with simple two-part
fractures and speciﬁcally asked whether patients with
simple two-part intertrochanteric fractures treated with IM
nailing had (1) lower risks of reoperation and (2) less pain
and better quality of life than patients treated with SHSs.
Patients and Methods
Since January 1, 2005, hip fracture operations in our
country have been recorded prospectively in the Norwe-
gian Hip Fracture Register (NHFR) [12]. Seventeen
thousand one hundred forty-eight primary operations for
intertrochanteric and subtrochanteric fractures were recor-
ded until December 31, 2010. For the current study, we
selected patients with two-part intertrochanteric fractures
(AO/OTA Type A1 [19]) treated with an SHS or an IM nail
(n = 7724). Operations performed with other implants
(n = 22) and operations for pathologic fractures (n = 59)
were excluded, leaving 7643 operations (6355 operations
with SHSs and 1288 with IM nails) for ﬁnal analyses
(Fig. 1). The surgeons classiﬁed the fractures according to
the AO/OTA classiﬁcation and also reported the patients’
baseline characteristics (age, sex, cognitive function,
American Society of Anesthesiologists [ASA] classiﬁca-
tion of morbidities) and details from the primary operations
(surgical time, type of anesthesia, antibiotic and thrombotic
prophylaxis). Overall, 71% of the patients were female, and
the mean age for both groups was 82 years. We found no
differences in the mean ASA scores, cognitive functions, or
preoperative quality of life (EQ-5DTM index score; Euro-
Qol Group, Rotterdam, The Netherlands) between the two
treatment groups (Table 1).
Power calculations, including the number of patients in
the SHS and IM nail groups (6355 and 1288, respectively),
were performed. We considered a difference in reoperation
percentages of 1% to 2% to be clinically relevant, and
detecting a signiﬁcant difference in reoperations of 2%
could be obtained with a power of 85% by using our
numbers of patients. Accordingly, our study had sufﬁcient
power to detect a clinically important difference of this
size.
The SHS has remained the most commonly used implant
in Norway for treatment of all intertrochanteric and subtro-
chanteric fractures [21]. In our study, compression hip screws
(AMBI1/CLASSIC Hip Screw System; Smith & Nephew,
London, UK) and dynamic hip screws (Dynamic Hip System
screw/blade; Synthes GmbH, Basel, Switzerland) were the
two most frequently used SHSs. A trochanteric stabilizing
platewas added in 8%of these operations, possibly to prevent
fracture of a small and osteoporotic lateral spike of the
trochanter at mobilization. The second and third generations
of the Gamma3TM Locking Nail (Stryker Corp) and the
TrigenTM IntertanTM Trochanteric Antegrade Nail (Smith &
Nephew) were the most commonly used IM nails. Long nails
were used in 4% of the nailing procedures (Table 2).
Operating surgeons from 55 hospitals nationwide
reported primary operations and reoperations, with causes
and type of reoperation, to the NHFR. Failure of the ﬁxa-
tion, nonunions or malunions, femoral head necroses, local
pain from protruding hardware, infections, hematomas,
cutouts, periimplant fractures, and other occurrences were
the options for reporting causes of reoperation. Removal of
the implants, resection arthroplasties, unipolar or bipolar
hemiarthroplasties, reﬁxation, de´bridement for infections,
and other occurrences were the options for reporting type
of reoperations. More than one cause of reoperation and
more than one type of reoperation were recorded for some
patients. Patients whose reoperations were THAs (n = 81),
however, were reported to the Norwegian Arthroplasty
Register. The NHFR obtained these data and linked them
to the primary operations, but we had no detailed infor-
mation regarding the causes of reoperations for these
patients.
Questionnaires regarding quality of life (EQ-5DTM
health questionnaire) [28] and pain were sent to the patients
at 4, 12, and 36 months postoperatively. A preoperative
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quality-of-life status was recorded in retrospect together
with the 4-month questionnaire. At 4 months, 1029 patients
with an IM nail received the questionnaires, and 515 and
503 answered the questionnaires regarding pain and
EQ-5DTM, respectively, giving a response rate of approx-
imately 50% (Fig. 1). In the questionnaires, the patients
were asked to report pain from the surgically treated hip,
using a VAS (0 indicating no pain, 100 indicating
unbearable pain). The EQ-5DTM questionnaire contains
ﬁve factors (mobility, degree of self-care, ability to per-
form usual activities, pain/discomfort, and anxiety/
depression) rated at three levels (no problems, some
problems, severe problems). Derived from these questions,
the EQ-5DTM index score gives a value, with a maximum
score of 1.0 indicating a very good quality of life and a
score of 0 being equivalent to death.
All patients were observed for any reason for reopera-
tion until December 31, 2010 (mean followup, 1 year 10
months; range, 0–6 years). The questionnaires regarding
pain and quality of life were sent to all living patients with
IM nails or SHSs with a trochanteric stabilizing plate
during followup from 2005 to 2010. Similarly, all patients
with simple SHS operations in 2005, 2006, and 2010
received this questionnaire. Of the patients treated with a
simple SHS in 2007 to 2009, however, owing to lack of
resources, only a randomly selected subgroup of patients
was asked to answer the questionnaires.
We estimated the cumulative 1- and 3-year reoperation
risks for the two treatment groups using a Kaplan-Meier
survival analysis. The log-rank test was used to detect dif-
ferences. Patients without reoperations were censored at
their dates of death or emigration or at the end of followup
(December 31, 2010). The National Population Register
provided death and emigration information. In addition,
relative differences in reoperation rates (relative risk [RR])
between the implant types were estimated in a multiple Cox
regression model with adjustments for possible confound-
ing factors (age, sex, ASA class, cognitive impairment).
Fig. 1 A ﬂowchart of the patients and
followup assessments is shown.
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Patients without complete information regarding their ASA
classes and cognitive impairments (n = 290) were excluded
from the regression analysis. The mortality during followup
was determined with Kaplan-Meier analyses. Differences in
mean pain and quality of life (EQ-5DTM index score) scores
were analyzed using Student’s t-test, while categorical
outcome variables (EQ-5DTM mobility and usual activity)
were analyzed using the Pearson chi-square test. We used
PASW1 Statistics Software (Version 18.0; SPSS Inc,
Chicago, IL, USA) for all statistical analyses.
Results
We found a higher (p = 0.001) 1-year reoperation rate for
patients treated with IM nails than for those treated with
SHSs (4.2% and 2.4%, respectively). Two-hundred forty-
nine reoperations were identiﬁed. At 3 years, the reoperation
rates were 7.1% for IM nails and 4.5% for SHSs (p\0.001)
(Fig. 2). There was an overall 61% increased (p = 0.002) risk
of reoperation after IM nailing, compared with that after
using an SHS (RR, 1.61; 95% CI, 1.19–2.17). Comorbidity
(ASA class) and sex did not inﬂuence the reoperation rates,
whereas cognitively impaired patients had a lower (p\
0.001) reoperation risk than those who were cognitively
lucid (RR, 0.44; 95% CI, 0.28–0.68). In addition, older (p =
0.049) age reduced the reoperation risk (Table 3). Failure of
the ﬁxation was the most common reason for reoperation in
both groups (0.8%), andwe found no differences between the
two groups for most reasons for reoperations. However, the
rates of periimplant fractures (p = 0.027) and reoperations
attributable to implant-related pain (p = 0.043) were higher
in the IM nail group. Accordingly, implant removal was
more frequent (p = 0.028) in that group. Otherwise, the dis-
tribution of types of reoperations was similar for the two
groups, but reoperations in the SHS group more frequently
were recorded with a combination of reasons for reoperation
(not just one reason) (Table 4). We found a higher (p =
0.016) reoperation rate for the 52 patients with a long nail in
our study (six of 52 versus 54 of 1236).
Table 2. Implants used
Implant Number of hips
Sliding hip screws
Compression hip screw (AMBI1/CLASSIC
Hip Screw System)*
3887 (61%)
Dynamic hip screw (Dynamic Hip System) 1929 (30%)
Locking compression plate
(Dynamic Hip System)
492 (8%)
Omega PlusTM 43 (0.7%)
Other/missing data 4 (0%)
Total 6355 (100%)
Intramedullary nails
Gamma3TM Locking Nail 699 (54%)
TrigenTM IntertanTM* 355 (28%)
Trochanteric-GammaTM 154 (12%)
Proximal femoral nail-antirotation 51 (4%)
Proximal femoral nail 11 (0.9%)
Intramedullary hip screw* 10 (0.8%)
Other nails/missing data 8 (0.6%
Total 1288 (100%)
* Smith & Nephew, London, UK; Synthes, Basel, Switzerland;
Stryker Corp, Kalamazoo, MI, USA.
Table 1. Baseline characteristics of the two groups
Characteristic Sliding hip
screw
Intramedullary
nail
p value
Total number of hips
(n = 7643)
6355 (83%) 1288 (17%)
Age (years) (n = 7643)* 82 (10) 82 (10) 0.22
Sex (number of hips)
(n = 7643)
0.24
Female 4515 (71%) 936 (73%)
ASA type (number of hips)
(n = 7520)
6252 1268 0.007
1 463 (7%) 66 (5%)
2 2224 (36%) 506 (40%)
3 3216 (51%) 629 (50%)
4 337 (5%) 66 (5%)
5 12 (0.2%) 1 (0.1%)
ASA score* 2.55 (0.7) 2.55 (0.7) 0.88
Cognitive impairment
(number of hips)
(n = 7453)
6198 1255 0.10
Yes 1522 (25%) 288 (23%)
No 4009 (65%) 808 (64%)
Uncertain 667 (11%) 159 (13%)
Preoperative EQ-5DTM
index score*
(n = 2038)
0.69 (0.28) 0.69 (0.29) 0.71
Surgical time (minutes)*
(n = 7643)
52 (25) 51 (23) 0.029
Anesthesia (n = 7643) 0.67
Spinal 90% 90%
General 6% 6%
Other or missing 4% 4%
Antibiotic prophylaxis
(n = 7643)
\ 0.001
Yes 95% 86%
No 5% 13%
Missing value 0.6% 0.8%
Thrombosis prophylaxis 99% 99% 0.63
* Values are expressed as mean, with SD in parentheses; Student’s t-
test; Pearson chi-square test; ASA = American Society of
Anesthesiologists.
1382 Matre et al. Clinical Orthopaedics and Related Research1
123
The average scores for pain were similar for the two
implant groups at all times during the followup (Table 5).
Four months postoperatively, the mean VAS pain scores
were 28 and 29 for the IM nail and SHS, respectively (p =
0.332); they then decreased to 22 and 23, respectively, 3
years postoperatively (p = 0.845). We found no major
differences between the two treatment groups in the qual-
ity-of-life assessments (Table 5). After analyzing the ﬁve
factors of the EQ-5DTM questionnaire separately, however,
we found, after 1 postoperative year, patients in the SHS
group reported more problems regarding their mobility and
performing usual activities.
We also found the average surgical times for the two
operative methods were almost identical: 52 minutes for
the SHS group and 51 minutes for the IM nail group (p =
0.029). Mortality rates after 1 postoperative year were 25%
for the SHS group and 23% for the IM nail group (p =
0.224).
Discussion
There has been a trend toward more IM nailing in inter-
trochanteric fractures, but this trend has not been based on
current evidence [2, 26]. Historically, higher failure rates
Fig. 2 Kaplan-Meier analysis found cumulative reoperation rates of
4.2% and 2.4% at 1 year and 7.1% and 4.5% at 3 years for IM nails
and SHSs, respectively.
Table 3. Cox regression analysis of factors with possible inﬂuences
on the risk of reoperation
Factor Relative risk 95% CI p value
Type of implant
Sliding hip screw 1
Intramedullary nail 1.61 1.19–2.17 0.002
Sex
Male 1
Female 1.11 0.82–1.49 0.51
Age* 0.99 0.98–1.00 0.049
ASA type
1 1
2 1.07 0.69–1.67 0.76
3 0.93 0.59–1.45 0.74
4 1.12 0.52–2.42 0.77
Cognitive impairment
No 1
Uncertain 0.79 0.50–1.24 0.31
Yes 0.44 0.29–0.69 \ 0.001
Patients were followed until reoperation, end of study inclusion, time
of emigration, time of patient’s death; * risk reduction for each year
of older age; ASA = American Society of Anesthesiologists.
Table 4. Reason for and type of reoperation versus type of implant
in 249 hips with reoperations
Reoperations Number of hips p value*
Sliding hip
screw
Intramedullary
nail
Reoperated hips
(overall 249/7643
[3.3%])
189/6355 (3.0%) 60/1288 (4.7%) 0.002
Reported reasons
Failure of
osteosynthesis
54 (0.8%) 10 (0.8%) 0.79
Nonunion 18 (0.3%) 2 (0.2%) 0.41
Local pain from
implant
17 (0.3%) 8 (0.6%) 0.043
Infection (deep and
superﬁcial)
14 (0.2%) 2 (0.2%) 0.64
Cutout 17 (0.3%) 7 (0.5%) 0.11
Fracture around
implant
10 (0.2%) 6 (0.5%) 0.027
Other reasons 31 (0.5%) 12 (0.9%) 0.05
Unknown reasons
(THAs)
63 (1.0%) 18 (1.4%) 0.19
Types of reoperations§
Implant removal 25 (0.4%) 11 (0.9%) 0.028
New osteosynthesis 35 (0.6%) 10 (0.8%) 0.33
Bipolar
hemiarthroplasty
50 (0.8%) 16 (1.2%) 0.11
THA 63 (1.0%) 18 (1.4%) 0.19
Debridement
for infection
17 (0.3%) 3 (0.2%) 0.83
Others 8 (0.1%) 3 (0.2%) 0.36
* Pearson chi-square test; more than one reason per reoperation
possible; 208 reasons for reoperations were reported in 249 hips; for
the 81 patients whose reoperation was a THA, no detailed descrip-
tions of reasons for the reoperations were given; §reporting more than
one type of procedure was possible for each reoperation.
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have been observed after IM nailing compared with oper-
ations using SHSs [6, 16, 24]. To what extent modern nails
reduce complication rates or improve function (if at all)
remains to be shown. Currently, there is no consensus
regarding which implant, an SHS or an IM nail, is the best
for different intertrochanteric fractures. We therefore asked
whether patients with simple two-part intertrochanteric
fractures treated with IM nailing had (1) lower reoperation
rates and (2) less pain and better quality of life than
patients treated with SHSs.
There were some limitations to our study. First, as there
had been no randomization of the treatment allocation,
patient- and surgeon-related confounders may have been
present. With comparable baseline characteristics for the
groups, however, we believe the risk of any important bias
is less likely. In addition, data representing a national
average of hospitals and surgeons and the fact that the
implant selection usually reﬂects the policy in each hospital
rather than the choice of each surgeon should have reduced
the chance of bias. Second, our responder rate was low,
partly because of high mortality rates and the elderly study
population, but the large number of included patients may
have, to some extent, compensated for this. Underreporting
of complications and reoperations might be anticipated.
Even so, this probably should have affected both treatment
groups equally, and most likely, the difference in the
reoperation rates was real. Third, different IM nails and
SHSs were used in our study, and we did not examine pain,
function, or reoperation rates for each implant brand.
Therefore, our results may not be generalized to any nail or
SHS. Fourth, as the fracture classiﬁcation is performed by
the operating surgeons, and we have no radiographs
available in our register, this is also a source of uncertainty.
Finally, in a register study including thousands of patients,
even minor and clinically irrelevant differences might
become statistically signiﬁcant. Accordingly, our data
should be interpreted with caution. Nevertheless, where
RCTs may fail to detect small differences owing to limited
numbers of patients in rare events like reoperations in
particular, we believe the large number of patients in a
register study can add valuable information [14].
We found a higher rate of complications and reoperations
after IM nailing than after SHS operations for simple
two-part trochanteric fractures. Reoperation percentages of
2.4% and 4.2% for the SHS and IM nail groups at 1 year
were comparable to rates in other reports [1, 3, 16] on
intertrochanteric fractures. In line with our results, one
meta-analysis of RCTs [16] concluded the failure rate were
higher after IM nailing of stable intertrochanteric fractures
than after using an SHS, and nailing of these fractures was
not recommended. Our reoperation rates were slightly
higher than those reported for stable fractures in that review
but were lower than those reported in other studies [1, 3, 22]
where stable and unstable fractures were not separated.
Even though absolute numbers of reoperations vary among
studies, the consistent overall difference in favor of the SHS
Table 5. Pain and quality of life (with selected subcategories) in the two groups
Variable Sliding hip
screw
Intramedullary
nail
Mean difference
(95% CI)
p value
Mean VAS score for pain (points)
4 months 29 (n = 1504) 29 (n = 515) 0.9 (1.2 to 3.1) 0.40
1 year 26 (n = 1097) 24 (n = 378) 1.7 (0.8 to 4.1) 0.19
3 years 23 (n = 804) 22 (n = 136) 0.4 (3.3 to 4.0) 0.85
Mean EQ-5DTM index score*
Preoperative 0.69 (n = 1519) 0.69 (n = 519) 0.005 (0.023 to 0.034) 0.71
4 months 0.49 (n = 1508) 0.51 (n = 503) 0.017 (0.045 to 0.009) 0.20
1 year 0.55 (n = 1097) 0.58 (n = 376) 0.030 (0.061 to 0.001) 0.06
3 years 0.59 (n = 816) 0.59 (n = 134) 0.008 (0.061 to 0.044) 0.76
EQ-5DTM: mobility at 12 months 0.006
No problems 24% 32%
Some problems 72% 65%
Severe problems 4% 4%
EQ-5DTM: usual activities at 12 months 0.014
No problems 26% 33%
Some problems 47% 43%
Severe problems 27% 24%
* EQ-5DTM index score scale: 0 indicates a situation similar to death and 1 indicates the best possible quality of life; no signiﬁcant differences
were found at 4 months or 3 years or for other EQ-5DTM dimensions at any time.
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seems to have remained. The severity of the complications
and reasons for reoperation may vary among implant
groups. In our study we found more patients had reopera-
tions because of fracture around the implant and local pain
from the implant in the IM nail group. Otherwise we found
no differences in reasons for reoperation between the
groups, indicating a similar rate of minor or major compli-
cations in both groups. Most types of reoperations were
more frequent in the IM nail group, however, only ‘‘removal
of implants’’ was signiﬁcant. Postoperative femoral fracture
rates were high when using the ﬁrst few generations of IM
nails [4, 8, 10, 25]. Therefore, reported failure rates after IM
nailing, including nails no longer in use, may distort the
results in updated reviews [15, 18, 24]. This problem was
addressed in a meta-analysis by Bhandari et al. [6] who
assessed the change of postoperative femoral fracture rates
after GammaTM nailing with time. They found less femoral
fractures and no differences compared with the SHS in the
most recent studies. However, no studies published after
2005 or studies on other types of IM nails were included in
that review. In addition, others did not ﬁnd a similar time-
dependent change in the postoperative femoral fracture and
failure rates for IM nailing [7, 24]. We suspect some
underreporting of femoral fractures and subsequent reo-
perations in our study, as only six reoperations (0.5%) in the
IM nail group were caused by fractures around the implants.
These ﬁndings contrast with those in another study [11],
where a 6% rate of postoperative femoral fractures was
reported after IM nailing, clearly indicating this problem has
not been solved. Our data included only recent generations
of implants and indicated reoperation rates have continued
to be higher after IM nailing of simple two-part intertro-
chanteric fractures. In our study, 96% of the nailing
procedures were performed with short nails, and to what
extent a shift toward more long nails even in stable inter-
trochanteric fractures would reduce the number of
periimplant fractures remains unknown. However, despite a
higher rate of reoperations for long nails, periimplant frac-
tures were not the cause of reoperation in patients who were
treated with long nails.We found the reoperation rate among
cognitively impaired patients to be lower than that for
cognitively lucid patients. This is consistent with another
report [13] from our hip fracture register and might be
caused by these patients’ poorer abilities to express com-
plaints and/or differences in the indications for surgical
interventions.
We also found no difference in pain or quality of life
between the two implant groups during followup. The
assessment of pain for patients with hip fractures has not
been standardized, and several outcomes for pain have
been reported [9, 24]. Therefore, comparing results is dif-
ﬁcult. Nevertheless, regardless of the implant and out-
come measure used and in accordance with our results, two
meta-analyses [9, 24] reported no major differences in pain
between implants and operative methods in trochanteric
fractures. Our ﬁnding of no difference in the reported
quality of life between the implants, using the EQ-5DTM
index score, indicated the difference in reoperation rates
was not enough to inﬂuence the patients’ perception of
quality of life. After 1 postoperative year, however, more
patients in the IM nail group rated their mobility and ability
to perform usual activities with the best score. The dif-
ferences were minor and temporary, but these EQ-5DTM
dimensions describe important factors related to a patient’s
ability to maintain his or her independence. Quality-of-life
measures have been reported inconsistently in trials com-
paring the SHS and IM nail in intertrochanteric fractures
[9]. We were not aware of any other study assessing quality
of life using the EQ-5DTM questionnaire in cases of simple
two-part intertrochanteric fractures. In a RCT comparing
the GammaTM nail with the Medoff sliding plate (Swemac,
Linko¨ping, Sweden) in unstable intertrochanteric and
subtrochanteric fractures [20], the authors reported no
difference in EQ-5DTM index scores between the groups.
Overall, the most updated and thorough review of RCTs
[24] comparing SHSs and IM nails in intertrochanteric
fractures concluded there was no difference in terms of
quality-of-life issues, such as pain, walking ability, or the
number of patients regaining their prefracture levels of
independence after intertrochanteric fractures.
We found a higher rate of reoperations after IM nailing
than after use of the SHS in simple two-part intertrochan-
teric fractures, but we also found no clinically relevant
differences in pain or overall quality of life during the
followup assessments. Our study had several limitations,
but the ﬁndings seemed to be in accordance with meta-
analyses of RCTs. Despite modern trends suggesting
otherwise, in our opinion, the SHS still seems to be the
better treatment for simple two-part intertrochanteric
fractures compared with short IM nails.
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